Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.458 USD | +6.51% | -6.53% | +63.51% |
Business Summary
Number of employees: 61
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Life Sciences
87.6
%
| 0 | 90.7 % | 1 | 87.6 % | +122.28% |
Infrastructure
12.4
%
| 0 | 9.3 % | 0 | 12.4 % | +205.41% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
85.3
%
| 0 | 82.9 % | 1 | 85.3 % | +136.17% |
India
12.4
%
| 0 | 17.1 % | 0 | 12.4 % | +66.18% |
Colombia
2.3
%
| - | - | 0 | 2.3 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 29/05/29 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 09/18/09 |
Chief Tech/Sci/R&D Officer | - | - | |
Jagadeesh Rao
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/17/01 |
Rohit Goel
AUD | Comptroller/Controller/Auditor | 30 | 29/17/29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 29/05/29 |
Richard Prins
CHM | Chairman | 67 | 01/07/01 |
Director/Board Member | 78 | 18/22/18 | |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 09/18/09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,541,532 | 52,940,787 ( 79.56 %) | 0 | 79.56 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.51% | 30.26M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- IGC Stock
- Company IGC Pharma, Inc.